Dana Hu-Lowe
Corporate Officer/Principal en ADAGENE INC. .
Perfil
Dana Hu-Lowe's current job is Vice President-Global Product at Adagene, Inc. Dr. Hu-Lowe's former jobs include Executive Director & Head-Global Product at Turning Point Therapeutics, Inc. and Senior Director-Strategic Alliance & Program at Wellspring Biosciences, Inc. Dr. Hu-Lowe obtained a doctorate degree from the University of Mississippi in 1992 and an undergraduate degree from Beijing Normal University in 1984.
Cargos activos de Dana Hu-Lowe
| Empresas | Cargo | Inicio |
|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 01/11/2021 |
Antiguos cargos conocidos de Dana Hu-Lowe.
| Empresas | Cargo | Fin |
|---|---|---|
| TURG POIN | Director/Miembro de la Junta | 01/10/2021 |
| Wellspring Biosciences, Inc. | Corporate Officer/Principal | 01/03/2019 |
Formación de Dana Hu-Lowe.
| University of Mississippi | Doctorate Degree |
| Beijing Normal University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ADAGENE INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
| Wellspring Biosciences, Inc. |
- Bolsa de valores
- Insiders
- Dana Hu-Lowe